Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
Head and Neck cancers (HNC) are a heterogeneous group of upper aero-digestive tract
cancer and account for 931,922 new cases and 467,125 deaths worldwide. About 90% of …
cancer and account for 931,922 new cases and 467,125 deaths worldwide. About 90% of …
The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors
Abstract NSD1, NSD2, and NSD3 constitute the nuclear receptor-binding SET Domain
(NSD) family of histone 3 lysine 36 (H3K36) methyltransferases. These structurally similar …
(NSD) family of histone 3 lysine 36 (H3K36) methyltransferases. These structurally similar …
Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma
Chromatin dysregulation has emerged as an important mechanism of oncogenesis. To
develop targeted treatments, it is important to understand the transcriptomic consequences …
develop targeted treatments, it is important to understand the transcriptomic consequences …
DNA damage response mechanisms in head and neck cancer: significant implications for therapy and survival
C Papalouka, M Adamaki, P Batsaki… - International Journal of …, 2023 - mdpi.com
Head and neck cancer (HNC) is a term collectively used to describe a heterogeneous group
of tumors that arise in the oral cavity, larynx, nasopharynx, oropharynx, and hypopharynx …
of tumors that arise in the oral cavity, larynx, nasopharynx, oropharynx, and hypopharynx …
NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer
worldwide. Despite advances in therapeutic management and immunotherapy, the 5-year …
worldwide. Despite advances in therapeutic management and immunotherapy, the 5-year …
Role of NSD1 as potential therapeutic target in tumor
C Yang, K Wang, Q Liang, TT Tian, Z Zhong - Pharmacological Research, 2021 - Elsevier
Nuclear receptor binding SET Domain Protein 1 (NSD1) is a bifunctional transcriptional
regulatory protein that encodes histone methyltransferase. Mono-and di-methylation of …
regulatory protein that encodes histone methyltransferase. Mono-and di-methylation of …
[HTML][HTML] A novel defined hypoxia-related gene signature to predict the prognosis of oral squamous cell carcinoma
Y Han, X Wang, K Xia, T Su - Annals of Translational Medicine, 2021 - ncbi.nlm.nih.gov
Background Oral squamous cell carcinoma (OSCC), as the most common oral cancer
globally, is very harmful to people's health. Hypoxia is closely related to many cancers. In …
globally, is very harmful to people's health. Hypoxia is closely related to many cancers. In …
PIP4K2B Protein Regulation by NSD1 in HPV-Negative Head and Neck Squamous Cell Carcinoma
Simple Summary This study identified the PIP4K2B protein as a key target of NSD1 in head
and neck cancer. We found that PIP4K2B positively regulates the mTOR signaling pathway …
and neck cancer. We found that PIP4K2B positively regulates the mTOR signaling pathway …
Targeting KDM2A enhances T-cell infiltration in NSD1-deficient head and neck squamous cell carcinoma
In head and neck squamous cell carcinoma (HNSCC), a significant proportion of tumors
have inactivating mutations in the histone methyltransferase NSD1. In these tumors, NSD1 …
have inactivating mutations in the histone methyltransferase NSD1. In these tumors, NSD1 …
Global genome demethylation causes transcription-associated DNA double strand breaks in HPV-associated head and neck cancer cells
M Hajek, A Biktasova, A Sewell, C Gary, P Cantalupo… - Cancers, 2020 - mdpi.com
Simple Summary High levels of global genome methylation in HPV-associated head and
neck cancer prompted us to explore demethylation as a potential treatment by determining …
neck cancer prompted us to explore demethylation as a potential treatment by determining …